Avian Influenza
Infectious Diseases
7
Pipeline Programs
3
Companies
7
Clinical Trials
0
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
3
0
4
0
0
0
Early DiscoveryClinical DevelopmentMarket
Drug Modality Breakdown
Vaccine
2100%
+ 5 programs with unclassified modality
Competitive Landscape
3 companies ranked by most advanced pipeline stage
Allergy TherapeuticsUK - West Sussex
4 programs1
3
A/H7N9Phase 21 trial
AS03Phase 21 trial
AS03Phase 21 trial
H5 AC-Anhui RNA VaccinePhase 1Vaccine1 trial
Active Trials
+1 more trials
Trial Timeline
Clinical trial activity over time
2021
2022
2023
2024
2025
2026
Allergy TherapeuticsA/H7N9
Allergy TherapeuticsAS03
Allergy TherapeuticsAS03
NovartisH5N1 influenza vaccine
Allergy TherapeuticsH5 AC-Anhui RNA Vaccine
VaxartND1.1
VaxartND1.1
Clinical Trials (7)
Total enrollment: 47 patients across 7 trials
Safety/Efficacy Study of Seqirus A/H7N9 IIV With or Without MF59(R) Adjuvant to Prevent Avian Influenza
Start: Nov 2018Est. completion: Apr 2020
Phase 2Completed
Co-Administration of AS03 Adjuvanted A/H7N9 IIV With IIV4
Start: Feb 2018Est. completion: Jul 2019
Phase 2Completed
H7N9 Vaccination With and Without AS03 and Unadjuvanted H3N2v Vaccination: Standard and Systems Biology Analyses
Start: Nov 2016Est. completion: Feb 2018
Phase 2Completed
Safety and Immunogenicity of a Booster Dose of -H5N1 Influenza Vaccine
Start: Oct 2007Est. completion: Jun 200847 patients
Phase 2Completed
A Study to Evaluate the Safety and Immunogenicity of Two Doses of a Novel H5 Central Antigen mRNA-LNP in Healthy Adults
Start: Jun 2025Est. completion: May 2026
Phase 1Active Not Recruiting
Immunogenicity of ND1.1 by Delivery Directly to the Ileum
Start: Sep 2012Est. completion: Nov 2013
Phase 1Completed
Safety Study of an Oral Vaccine to Prevent Avian Influenza
Start: Apr 2011Est. completion: Sep 2012
Phase 1Completed
Related Jobs in Infectious Diseases
Senior Recruiter
Invivyd
New Haven, CT (Northeast preferred)
5h ago
$120K - $160K/yr
Senior Associate Scientist (contract), Upstream Polysaccharide Process Development
VaxCyte
San Carlos, California, United States
8h ago
$56/hr
Senior Associate Scientist (contract), Polysaccharide Analytical Development
VaxCyte
San Carlos, California, United States
8h ago
$56/hr
Director, Program Management
Metaphore Biotechnologies
Somerville, MA USA
12h ago
$179K - $237K/yr
Technician, Operations, DSP/ Technicien(ne) des opérations, DSP
Verona Pharma
CAN - Prince Edward Island - Charlottetown
Yesterday
$47K - $79K/yr
HVAC Maintenance Technician
Verona Pharma
USA - Delaware - Millsboro (Intervet)
Yesterday
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
3 companies competing in this space